- Home
- CYH vs QSI Comparison
CYH vs QSI Comparison
Compare CYH & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYH | QSI |
|---|---|---|
| Founded | 1985 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.2M | 184.2M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | CYH | QSI |
|---|---|---|
| Price | $2.87 | $0.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $3.57 | $1.00 |
| AVG Volume (30 Days) | 1.3M | ★ 2.9M |
| Earning Date | 04-22-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 196.67 | N/A |
| EPS | ★ 3.77 | N/A |
| Revenue | ★ $12,485,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.17 | $618.07 |
| P/E Ratio | $0.78 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $0.79 |
| 52 Week High | $4.43 | $3.10 |
Technical Indicators
Market Signals| Indicator | CYH | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 33.72 | 33.04 |
| Support Level | $2.41 | N/A |
| Resistance Level | $3.25 | $1.11 |
| Average True Range (ATR) | 0.14 | 0.06 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 7.09 | 0.88 |
Price Performance
Historical ComparisonAbout CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.